주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-24 17:07 (Wed)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
345 )
기사목록 보기 형태
제목형
요약형
포토형
[Exclusive] Invossa patent expired in 6 European countries
Nam Doo-hyun
2018.07.26 11:06
Which multinational drugmaker grew most rapidly in H1?
Nam Doo-hyun
2018.07.25 11:30
Will new patent help detect norovirus easily?
Nam Doo-hyun
2018.07.05 15:46
‘UCB Korea to keep pursuing patient value in neurology’
Nam Doo-hyun
2018.07.04 14:31
Biopharma stocks listed in H1 perform poorer than non-pharma peers
Nam Doo-hyun
2018.07.03 15:05
‘Government support for dementia tests might be ill-timed’
Nam Doo-hyun
2018.07.03 11:36
‘Bleeding risk lowest in Eliquis among NOACs for AF patients’
Nam Doo-hyun
2018.07.02 16:42
BMS Korea wins fight for Eliquis patent
Nam Doo-hyun
2018.06.29 14:28
Prognostic marker for childhood obesity complications wins patent
Nam Doo-hyun
2018.06.27 11:44
Antarctic sea microorganisms; a solution to blood shortage?
Nam Doo-hyun
2018.06.26 14:07
Korea’s drug exports to US, Europe on the rise
Nam Doo-hyun
2018.06.25 15:30
Chong Kun Dang topped in H1 clinical trial
Nam Doo-hyun
2018.06.21 10:57
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기